drug · small molecule
cenobamate
Marketedupdated 3mo agoby SK Life Science Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 3 investigational indications.
targets
Sodium channel alpha subunitGABA-A receptor; anion channel
all catalysts(0)
nothing on the calendar yet
Trials studying cenobamate
- phase4Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
- phase3A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
- phase3Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
- phase1Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
- phase3Cenobamate Open-Label Extension Study for YKP3089C025
- —Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
- phase3Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
- phase3ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 30, 2032
~6.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Jun 16, 2039method-of-use (U-3610)US 11654133
- Oct 30, 2032compositionUS 7598279
- Oct 30, 2032compositionUS 7598279
- Oct 30, 2032compositionUS 7598279
- Oct 30, 2032compositionUS 7598279
- Oct 30, 2032compositionUS 7598279
- Oct 30, 2032compositionUS 7598279
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that